Nachrichten zur Bavarian Nordic AS Aktie

Bavarian Nordic: Wichtige Mitteilung – so reagiert die Aktie

Bavarian Nordic startet in den USA den Vertrieb von JYNNEOS®, dem einzigen FDA-zugelassenen Mpox-Impfstoff.…

Bavarian Nordic A/S (BVNKF) Q4 2023 Earnings Call Transcript

…

Bavarian Nordic’s Chikungunya Vaccine Candidate Granted Accelerated Assessment by European Medicines Agency

COPENHAGEN, Denmark, February 23, 2024 – Bavarian Nordic A/S (OMX: BAVA) (“the Company”) today announced that the Committee for Medicinal…

ExpreS2ion’s Associated Company AdaptVac Receives Milestone Payment Following Completion of Bavarian Nordic’s Clinical Phase III Study for the COVID-19 Vaccine

Hørsholm, Denmark, 21 February 2024 – ExpreS[2]ion Biotech Holding AB’s affiliate ExpreS[2]ion Biotechnologies ApS (“ExpreS2ion") today announces that AdaptVac ApS…

Bavarian Nordic delivered record financial results in 2023

COPENHAGEN, Denmark, February 21, 2024 – Bavarian Nordic A/S (OMX: BAVA) today reports preliminary, unaudited financial results for 2023 and…

Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant Exercise

COPENHAGEN, Denmark, November 30, 2023 – Bavarian Nordic A/S (OMX: BAVA) announced today that the Companys share capital has been…

Bavarian Nordic A/S (BVNKF) Q3 2023 Earnings Call Transcript

…

CDC Advisors Recommend Mpox Shots For Routine Prevention Among At-Risk Adults—Here’s What To Know

There have been more than 30,000 mpox cases and 54 deaths reported in the U.S. but vaccine maker Bavarian Nordic…

Bavarian Nordic’s Mpox Vaccine Receives Recommendation from U.S. CDC Advisory Committee for Routine Use in Adults at Risk

COPENHAGEN, Denmark, October 25, 2023 – Bavarian Nordic A/S (OMX: BAVA) announced today that the U.S. Centers for Disease Control…

HC Andersen Capital Events 25/08: Mød topledelsen i Photocat, Hafnia, Agillic, Impero og Bavarian Nordic

HC Andersen Capital afholder i dag en række spændende events, hvor du kan møde og stille spørgsmål direkte til topledelsen.…

Bavarian Nordic A/S reports 1H results

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Bavarian Nordic: Umsatzexplosion von 278 Prozent – Aktie startet durch – ein weiterer Gewinner

Der europäische Impfstoff-Entwickler Bavarian Nordic kann zur Wochenmitte mit starken Halbjahreszahlen aufwarten. Mit einem Plus von zehn Prozent löst sich…

DAX leicht im Plus erwartet, Nvidia, Bavarian Nordic, BioNTech, Moderna, BASF, Nordex und Talanx im Fokus – das ist heute wichtig

Am Tag vor dem Beginn des Notenbanker-Treffens in Jackson Hole zeigt sich der DAX wohl weiter erholt. Rund zwei Stunden…

Bavarian Nordic Announces First Half 2023 Results

COPENHAGEN, Denmark, August 23, 2023 – Bavarian Nordic A/S (OMX: BAVA) announced today its interim financial results and business progress…

ExpreS2ion announces financial results for the second quarter 2023

Hørsholm, Denmark, 17 August 2023– ExpreS2ion Biotech Holding AB (“ExpreS2ion”) today announces its second quarter financial results for 2023. The…

Bavarian Nordic Reports Positive Phase 3 Topline Results for Chikungunya Virus Vaccine in Adults and Adolescents

COPENHAGEN, Denmark, August 6, 2023 – Bavarian Nordic A/S (OMX: BAVA) announced today positive topline results from a randomized, double-blind,…

Bavarian Nordic receives $120m contract for manufacturing of smallpox and mpox vaccine from U.S. government

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Bavarian Nordic Receives USD 120 Million Contract for the Manufacturing of Smallpox and Mpox Vaccine from the U.S. Government

COPENHAGEN, Denmark, August 3, 2023 – Bavarian Nordic A/S (OMX: BAVA) announced today that the U.S. Biomedical Advanced Research and…

Bavarian Nordic: "Bauchlandung"! Aktienanalyse

Kulmbach (www.aktiencheck.de) - Bavarian Nordic-Aktienanalyse von "Der Aktionär": Martin Weiss, stellvertretender Chefredakteur vom Anlegermagazin "Der Aktionär", nimmt die Aktie des Impfstoff-Entwicklers…

Microsoft, Alphabet, AMC Entertainment, Snap, Shopify, BioNTech, Bavarian Nordic - Opening Bell

Auf die Wall Street wartet eine spannende Woche. Der Terminkalender ist pickepackevoll. Zum einen steht die Sitzung der US-Notenbank am…

Bavarian Nordic: Bittere Pille für den Impfstoff-Entwickler! Aktienanalyse

Kulmbach (www.aktiencheck.de) - Bavarian Nordic-Aktienanalyse von "Der Aktionär": Michel Doepke vom Anlegermagazin "Der Aktionär" nimmt in einer aktuellen Aktienanalyse die Aktie…

Bavarian Nordic: Horror-News am Wochenende – Aktie bricht ein

Bittere Pille für den europäischen Impfstoff-Entwickler Bavarian Nordic: Am Wochenende gab die Gesellschaft bekannt, dass der Impfstoffkandidat gegen das Respiratorisches…

UPDATE 1-Bavarian Nordic ends RSV vaccine programme after poor trial results

... (Reuters) - Denmark-based Bavarian Nordic said on Saturday......…

Bavarian Nordic to discontinue RSV vaccine programme

...(Reuters) - Denmark-based Bavarian Nordic said on Saturday......…

XETR : Deletion of Instruments from XETRA - 17.07.2023

The following instruments on XETRA do have their last trading day on 17.07.2023. Die folgenden Instrumente auf XETRA haben ihren letzten…

Phase III topline results announced for the COVID-19 booster vaccine candidate

Hørsholm, Denmark, 27 June 2023 – ExpreS2ion Biotech Holding ABs affiliate ExpreS2ion Biotechnologies ApS (“ExpreS2ion") today provides an update on…

Bavarian Nordic Reports Phase 3 Topline Results for its COVID-19 Booster Vaccine Candidate

COPENHAGEN, Denmark, June 27, 2023 – Bavarian Nordic A/S (OMX: BAVA) today reported topline results from a Phase 3 non-inferiority…

Bavarian Nordic to Supply Smallpox Vaccines for EU Strategic Reserve

COPENHAGEN, Denmark, June 23, 2023 – Bavarian Nordic A/S (OMX: BAVA) announced today, that it has been awarded a contract…

Bavarian Nordic Beefs Up Chikungunya Vaccine Race With Valneva With Encouraging Late-Stage Trial Data

Bavarian Nordic A/S's (OTC: BVNRY) phase 3 chikungunya virus vaccine (CHIKV VLP (PXVX0317) clinical trial has hit its primary endpoint in read…

12-month durability data announced for ABNCoV2 Phase II clinical trial

Hørsholm, Denmark, 16 June 2023 – ExpreS2ion Biotech Holding ABs affiliate ExpreS2ion Biotechnologies ApS (“ExpreS2ion") today provides an update on…

Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such

COPENHAGEN, Denmark, June 12, 2023 – Bavarian Nordic A/S (OMX: BAVA) has today received information about the following transactions of…

Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such

COPENHAGEN, Denmark, May 23, 2023 – Bavarian Nordic A/S (OMX: BAVA) has today received information about the following transactions of…

Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant Exercise

COPENHAGEN, Denmark, May 23, 2023 – Bavarian Nordic A/S (OMX: BAVA) announced today that the Companys share capital has been…

UPDATE 1-Those at high risk of mpox should get 2 doses of Bavarian Nordic vaccine, US CDC says

...) By Leroy Leo May 18 (Reuters) - The U.S. Centers for Disease Control......…

Bavarian Nordic monkeypox vaccine Jynneos more effective with two doses

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

People at high risk to mpox should get 2 doses of Bavarian Nordic vaccine, US CDC says

...(Reuters) - The U.S. Centers for Disease Control and Prevention......…

Bavarian Nordic – Transactions in Connection with Share Buy-Back Program and Termination of Share Buy-Back Program

COPENHAGEN, Denmark, May 17, 2023 – Bavarian Nordic A/S (OMX: BAVA) announces that the share buy-back program, which was announced…

Bavarian Nordic Completes Acquisition of Travel Vaccine Portfolio from Emergent BioSolutions

COPENHAGEN, Denmark, May 15, 2023 – Bavarian Nordic A/S (OMX: BAVA) announced today that it has completed its acquisition of…

Bavarian Nordic A/S GAAP EPS of DKK5.10, revenue of DKK1.25B

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Bavarian Nordic Launches Share Buy-Back Program to Hedge Incentive Scheme Obligations

COPENHAGEN, Denmark, May 9, 2023 – Bavarian Nordic A/S (OMX: BAVA) announced today the initiation of a new share buy-back…

Bavarian Nordic Announces Interim Results for the First Three Months of 2023

COPENHAGEN, Denmark, May 9, 2023 – Bavarian Nordic A/S (OMX: BAVA) announced today its interim financial results and business progress…

Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such

COPENHAGEN, Denmark, May 1, 2023 – Bavarian Nordic A/S (OMX: BAVA) has today received information about the following transactions of…

Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such

COPENHAGEN, Denmark, April 25, 2023 – Bavarian Nordic A/S (OMX: BAVA) has today received information about the following transactions of…

Mpox outbreak was wake-up call for smallpox preparation, vaccine maker Bavarian Nordic says

Bavarian Nordic plans to sharply scale up production of its Jynneos vaccine to prepare for a smallpox emergency, CEO Paul…

Resolutions of the Annual General Meeting 2023 of Bavarian Nordic A/S

COPENHAGEN, Denmark, March 30, 2023 – Bavarian Nordic A/S (OMX: BAVA) today held the Annual General Meeting with the following…

Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such

COPENHAGEN, Denmark, March 17, 2023 – Bavarian Nordic A/S (OMX: BAVA) has today received information about the following transactions of…

dpa-AFX ProFeed